Adrianna Rodriguez, USA Today Research has shown people of color are disproportionately impacted by drug overdose deaths and access to treatment is limited. But even if they do find treatment, a new study found white patients receive care for an opioid use disorder longer than Black and Hispanic patients. Researchers at Harvard Medical School randomly sampled a … Read more
The analysis of 15 years of prescription data showed that the racial disparities are widening. By Emily Baumgaertner, New York Times November 9, 2022 Researchers have long known that racial and ethnic minorities are less likely to be prescribed lifesaving addiction treatment options than white people. But even when Black and Hispanic patients start a … Read more
Dr. Jag Chhatwal has announced Dr. Carrie Cunningham (nee Lubitz) is the Associate Director of the Institute for Technology Assessment (ITA). Dr. Cunningham is an Associate Professor of Surgery at Harvard Medical School, Section head of the Massachusetts General Hospital Endocrine Surgery Unit, and has been a Senior Scientist at the ITA since 2013. Dr. Cunningham matriculated … Read more
A study simulating a population of 30 million people 65 and older found that wrist-wearable devices are more cost-effective than traditional electrocardiograms and pulse palpation for atrial fibrillation (AF) screening, and that they are associated with a reduction in stroke incidence. August 24, 2022 — Screening individuals for atrial fibrillation (AF) using wearable devices is more cost-effective than screening … Read more
A data-driven simulation model designed to help policymakers to better understand and address the nation’s rampant opioid crisis has been developed by a team of scientists at Massachusetts General Hospital. In a study in the journal PNAS, researchers report that the model, known as SOURCE (Simulation of Opioid Use, Response, Consequences, and Effects), presents the … Read more
Amy Knudsen, PhD, senior scientist at the MGH ITA and Assistant Professor of Radiology at Harvard Medical School, received a Celebration of Science Recognition Award from the MGH Executive Committee on Research (ECOR) for her work that informed colorectal cancer screening recommendations in the U.S. The award comes with a $1,000 honorarium and an opportunity … Read more
On February 20th, Dr. James Brink, Radiologist-in-Chief at Massachusetts General Hospital announced that Jagpreet Chhatwal, PhD, will succeed Pari Pandharipande, MD, MPH, FACR, as Director of the ITA following her transition to the Ohio State University College of Medicine as Chair of Radiology. Jagpreet Chhatwal’s research is centered in decision science, data analytics, outcomes research, … Read more
Liver disease is projected to be one of those, with 8,000 additional deaths from alcohol-related liver disease, 18,700 cases of liver failure and 1,000 cases of liver cancer by 2040. The reason is the increase in alcohol sales and consumption during the early part of the pandemic, according to a new study. “Our findings highlight … Read more
An updated projection model shows COVID-19 infections fueled by the Omicron variant are expected to surge dramatically in the coming weeks in the United States and across the world, though it is less likely to result in severe outcomes like hospitalizations and deaths than the Delta variant. The Institute for Health Metrics and Evaluation at … Read more
RSNA News Release OAK BROOK, Ill. (June 10, 2008) — Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current and former smokers, but it won’t protect them from other causes of death associated with smoking, according to a new study published in the July issue of the journal … Read more
